| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1528-1157.1996.TB06037.X |
| P698 | PubMed publication ID | 8941040 |
| P2093 | author name string | Morrell MJ | |
| P2860 | cites work | Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects | Q22337418 |
| Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group | Q28245647 | ||
| Genetic predisposition to phenytoin-induced birth defects | Q34558227 | ||
| Endothelins and the nervous system | Q36753602 | ||
| Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies | Q37025275 | ||
| The fetal hydantoin syndrome | Q39338123 | ||
| Anticonvulsants and parental epilepsy in the development of birth defects | Q39367479 | ||
| Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs | Q39667491 | ||
| A possible primidone embryopathy | Q41635701 | ||
| In vitro screening for anticonvulsant-induced teratogenesis in neural primary cultures and cell lines | Q41754966 | ||
| Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background | Q41931465 | ||
| Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children | Q41935146 | ||
| The fetal valproate syndrome | Q42249396 | ||
| In-utero exposure to valproate and neural tube defects. | Q42685178 | ||
| Intelligence of children of epileptic mothers | Q43680106 | ||
| Possible interaction between oxcarbazepine and an oral contraceptive | Q43807984 | ||
| Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study | Q43986196 | ||
| Serum folic acid levels in epileptic mothers and their relationship to congenital malformations | Q44813696 | ||
| Effect of carbamazepine and valproate on bone mineral density | Q45082327 | ||
| Ovulatory Function in Epilepsy | Q45934642 | ||
| Reproductive endocrine disorders in women with partial seizures of temporal lobe origin | Q48363627 | ||
| Japanese crossed Wernicke's aphasia | Q48553441 | ||
| Effects of anticonvulsant drugs on fetal mouse palates cultured in vitro. | Q51634795 | ||
| Derangement of the hypothalamic GnRH pulse generator in women with epilepsy | Q57991940 | ||
| An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy | Q58450039 | ||
| P921 | main subject | human pregnancy | Q11995 |
| P304 | page(s) | S34-44 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome | |
| P478 | volume | 37 Suppl 6 |
| Q35664266 | Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians |
| Q33999176 | Anticonvulsants and breast feeding: a critical review |
| Q48291384 | Antiepileptic drug treatment: clinical considerations and concerns. |
| Q35922132 | Antiepileptic drugs in the 21st century. |
| Q33876238 | Assessing the safety of drugs in pregnancy: the role of prospective cohort studies |
| Q42926141 | Comparative pharmacodynamic and pharmacokinetic analysis of two anticonvulsant halo derivatives of 2,2,3,3-tetramethylcyclopropanecarboxamide, an amide of a cyclic analog of valproic acid. |
| Q34149295 | Contemporary management of epilepsy in pregnancy |
| Q64985073 | Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid. |
| Q44663815 | Do women with epilepsy have increased frequency of menstrual disturbances? |
| Q33795580 | Drugs for epilepsy have teratogenic risks |
| Q34104142 | Epilepsy in Pregnant Women |
| Q41690724 | Gender-related considerations in clinical pharmacology and drug therapeutics. |
| Q34188307 | Issues for women with epilepsy |
| Q38113674 | Management of juvenile myoclonic epilepsy |
| Q27024074 | On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring |
| Q34445634 | Oxcarbazepine in the treatment of epilepsy |
| Q36554228 | Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures |
| Q40849421 | Pharmacotherapeutic issues for women of childbearing age with epilepsy |
| Q73839650 | Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations |
| Q47840317 | Recorded pregnancy histories of the mothers of singletons and the mothers of twins: a longitudinal comparison |
| Q55007210 | Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? |
| Q43472317 | Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy |
| Q34969670 | Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing? |
| Q36425094 | The course and outcome of pregnancy and neonatal situation in epileptic women |
| Q34314537 | The star systems: overview and use in determining antiepileptic drug choice |
| Q46169408 | Topiramate in pregnancy and breastfeeding |
| Q44334635 | Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo |
| Q34725743 | Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations |
| Q46209070 | Unilateral radius aplasia due to lamotrigine and oxcarbazepine use in pregnancy |
| Q38895955 | Update on management of epilepsy in women for the non-neurologist |
| Q80110596 | [Safety of antiepileptic drugs during pregnancy] |
Search more.